• Hypertrophic Cardiomyopathy (HCM)
  • Eyecare
  • Urothelial Carcinoma
  • Hemophilia
  • Heart Failure
  • Vaccines
  • Neonatal Care
  • Type II Inflammation
  • Substance Use Disorder
  • Gene Therapy
  • Lung Cancer
  • Spinal Muscular Atrophy
  • HIV
  • Post-Acute Care
  • Liver Disease
  • Asthma
  • Atrial Fibrillation
  • COVID-19
  • Cardiovascular Diseases
  • Prescription Digital Therapeutics
  • Reproductive Health
  • The Improving Patient Access Podcast
  • Blood Cancer
  • Ulcerative Colitis
  • Respiratory Conditions
  • Multiple Sclerosis
  • Digital Health
  • Population Health
  • Sleep Disorders
  • Biosimilars
  • Plaque Psoriasis
  • Leukemia and Lymphoma
  • Oncology
  • Pediatrics
  • Urology
  • Obstetrics-Gynecology & Women's Health
  • Opioids
  • Solid Tumors
  • Autoimmune Diseases
  • Dermatology
  • Diabetes
  • Mental Health

Supreme court to rule on AWP laws


Washington, D.C. - The high court heard arguments last month in a case(Kentucky Association of Health Plans vs. Miller) charging that a Kentuckystate any-willing-provider (AWP) law violates the Employee Retirement IncomeSecurity Act (ERISA). Kentucky insurers urged the Supreme Court to overturna lower court decision that the state law regulates insurance and thus isnot subject to the ERISA preemption. The managed care community maintainsthat the proliferation of AWP laws is undermining their ability to controlcosts and hopes that the U.S. Supreme Court will issue a strong ruling thisspring to curb this trend.

Related Videos
Related Content
© 2023 MJH Life Sciences

All rights reserved.